The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy
Frederick Health Hospital Faces 5 Lawsuits Following Ransomware Attack
Arkansas Methodist Medical Center and Baptist Memorial Health Care to Merge
Ground Broken on Intermountain Saratoga Springs Multi-Specialty Clinic
Electrical Fire Tests Resilience of Massachusetts Hospital